tryptophan has been researched along with thromboplastin in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 6 (35.29) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Horowitz, HI; Vigliano, EM | 1 |
| Du, J; Guha, A; Hasselbacher, CA; Kohanski, RA; Lam, W; Lin, TC; Polikarpov, I; Rusinova, E; Rusinova, R; Waxman, E | 1 |
| Boys, CW; Edgington, TS; Kelly, CR; Martin, DM; Polikarpov, I; Ruf, W; Schullek, JR; Tuddenham, EG | 1 |
| Emi, N; Kojima, T; Matsushita, T; Saito, H; Takahashi, I | 1 |
| Nesheim, ME; Stevens, WK | 1 |
| Hasselbacher, CA; Laws, WR; Ross, JB; Rusinova, E; Schwartz, GP; Waxman, E | 1 |
| Luck, LA; Nemerson, Y; Ross, JB; Rusinova, E; Zemsky, J | 1 |
| Hamato, N; Hara, S; Kamei, K; Kato, H; Nishino, T; Ohshima, K; Sato, S; Takano, R; Yamamoto, R | 1 |
| Andersson, D; Carlsson, U; Freskgård, PO | 1 |
| Exner, M; Gmeiner, BM; Held, I; Hermann, M; Hofbauer, R; Kapiotis, S; Quehenberger, P; Speiser, W | 1 |
| Alexander, KA; Kane, WH; Kim, SW; Peng, W; Quinn-Allen, MA | 1 |
| Carlsson, K; Carlsson, U; Hammarström, P; Herland, A; Persson, E; Svensson, M; Wiréhn, J | 1 |
| Mysliwiec, M; Pawlak, D; Pawlak, K; Tankiewicz, J | 1 |
| Mysliwiec, M; Pawlak, D; Pawlak, K | 1 |
| Andry, C; Arinze, N; Belghasem, M; Chitalia, VC; Francis, JM; Lee, N; Lyle, C; Napolene, MA; Ravid, K; Richards, S; Roth, D; Spencer, C; Thompson, C; Walker, J; Whelan, SA; Yin, W | 1 |
| Koklic, T; Lentz, BR; Majumder, R; Sengupta, T | 1 |
| Arinze, N; Belghasem, M; Chitalia, VC; Dember, LM; Lee, N; Lotfollahzadeh, S; Napoleon, MA; Ravid, K; Richards, S; Russell, TL; Walker, JA; Whelan, SA; Yoo, SB | 1 |
17 other study(ies) available for tryptophan and thromboplastin
| Article | Year |
|---|---|
Bleeding syndrome in a patient with IgA myeloma: interaction of protein and connective tissue.
Topics: Aged; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Blood Protein Disorders; Calcium; Collagen; Connective Tissue; Fibrin; Fibrinogen; gamma-Globulins; Hemorrhagic Disorders; Humans; Male; Multiple Myeloma; Nitrogen Mustard Compounds; Plasmapheresis; Prothrombin Time; Thromboplastin; Tryptophan | 1967 |
Environments of the four tryptophans in the extracellular domain of human tissue factor: comparison of results from absorption and fluorescence difference spectra of tryptophan replacement mutants with the crystal structure of the wild-type protein.
Topics: Base Sequence; Circular Dichroism; Drug Stability; Factor VIIa; Humans; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Oligodeoxyribonucleotides; Phenylalanine; Point Mutation; Protein Conformation; Protein Structure, Secondary; Recombinant Proteins; Restriction Mapping; Spectrometry, Fluorescence; Thromboplastin; Tryptophan; Tyrosine | 1995 |
Energetic contributions and topographical organization of ligand binding residues of tissue factor.
Topics: Aspartic Acid; Binding Sites; Extracellular Space; Factor VIIa; Humans; Ligands; Models, Molecular; Mutagenesis, Site-Directed; Structure-Activity Relationship; Thromboplastin; Tryptophan | 1995 |
Impaired human tissue factor-mediated activity in blood clotting factor VIINagoya (Arg304-->Trp). Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor.
Topics: Adult; Animals; Arginine; Base Sequence; Binding Sites; Blood Coagulation; Catalysis; Cattle; DNA Primers; Factor VII; Factor X; Humans; Hydrolysis; Male; Molecular Sequence Data; Mutation; Recombinant Proteins; Sequence Analysis, DNA; Thromboplastin; Tryptophan | 1994 |
Structural changes in the protease domain of prothrombin upon activation as assessed by N-bromosuccinimide modification of tryptophan residues in prethrombin-2 and thrombin.
Topics: Amino Acid Sequence; Animals; Binding Sites; Bromosuccinimide; Cattle; Chromatography, High Pressure Liquid; Endopeptidases; Enzyme Activation; Enzyme Precursors; Factor V; Factor X; Histidine; Kinetics; Peptide Fragments; Prothrombin; Spectrometry, Fluorescence; Thrombin; Thromboplastin; Trypsin; Tryptophan | 1993 |
Determination of the tryptophan:tyrosine ratio in proteins.
Topics: Amino Acid Sequence; Humans; Molecular Sequence Data; Proteins; Recombinant Proteins; Spectrophotometry, Ultraviolet; Thromboplastin; Tryptophan; Tyrosine | 1993 |
Probing local environments of tryptophan residues in proteins: comparison of 19F nuclear magnetic resonance results with the intrinsic fluorescence of soluble human tissue factor.
Topics: Circular Dichroism; Crystallography, X-Ray; Fluorine; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; Mutagenesis, Site-Directed; Protein Conformation; Recombinant Proteins; Solvents; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Thromboplastin; Tryptophan | 1999 |
Effect of P(2)' site tryptophan and P(20)' site deletion of Momordica charantia trypsin inhibitor II on inhibition of proteinases.
Topics: Amino Acid Sequence; Factor IXa; Factor VIIa; Factor X; Humans; Molecular Sequence Data; Plant Proteins; Sequence Deletion; Sequence Homology, Amino Acid; Thromboplastin; Trypsin Inhibitors; Tryptophan | 2000 |
Contribution of tryptophan residues to the CD spectrum of the extracellular domain of human tissue factor: application in folding studies and prediction of secondary structure.
Topics: Circular Dichroism; Factor VIIa; Humans; Kinetics; Membrane Proteins; Mutagenesis, Site-Directed; Protein Folding; Protein Structure, Secondary; Protein Structure, Tertiary; Thromboplastin; Tryptophan | 2001 |
Genistein prevents the glucose autoxidation mediated atherogenic modification of low density lipoprotein.
Topics: Cells, Cultured; Diet, Atherogenic; Endothelium, Vascular; Fluorescence; Genistein; Glucose; Glycine max; Hemoglobins; Humans; Isoflavones; Lipoproteins, LDL; Male; Oxidation-Reduction; Serum Albumin, Bovine; Thiobarbituric Acid Reactive Substances; Thromboplastin; Tryptophan | 2001 |
Trp2063 and Trp2064 in the factor Va C2 domain are required for high-affinity binding to phospholipid membranes but not for assembly of the prothrombinase complex.
Topics: Alanine; Amino Acid Substitution; Animals; Cattle; Cell Line; COS Cells; Factor Va; Fluorescence Resonance Energy Transfer; Humans; Lipid Bilayers; Moths; Phosphatidylserines; Phospholipids; Protein Binding; Protein Processing, Post-Translational; Protein Structure, Tertiary; Recombinant Proteins; Surface Plasmon Resonance; Thromboplastin; Tryptophan | 2004 |
Activity, folding, misfolding, and aggregation in vitro of the naturally occurring human tissue factor mutant R200W.
Topics: Amyloid; Anilino Naphthalenesulfonates; Arginine; Benzothiazoles; Extracellular Space; Factor VIIa; Genetic Carrier Screening; Humans; Kinetics; Mutation; Nephelometry and Turbidimetry; Protein Binding; Protein Denaturation; Protein Folding; Spectrometry, Fluorescence; Substrate Specificity; Thiazoles; Thromboplastin; Tryptophan | 2005 |
Tissue factor/its pathway inhibitor system and kynurenines in chronic kidney disease patients on conservative treatment.
Topics: Adult; Aged; Case-Control Studies; Chronic Disease; Female; Humans; Kidney Diseases; Kynurenine; Lipoproteins; Male; Middle Aged; Thromboplastin; Tryptophan | 2009 |
Haemostatic system, biochemical profiles, kynurenines and the prevalence of cardiovascular disease in peritoneally dialyzed patients.
Topics: Adult; Antifibrinolytic Agents; Cardiovascular Diseases; Case-Control Studies; Cross-Sectional Studies; Fasting; Female; Fibrinolysin; Hemostasis; Humans; Kynurenic Acid; Kynurenine; Male; Middle Aged; Peptide Fragments; Peritoneal Dialysis, Continuous Ambulatory; Plasminogen Activator Inhibitor 1; Poland; Prevalence; Prothrombin; Quinolinic Acid; Receptors, Urokinase Plasminogen Activator; Thromboplastin; Tryptophan; Urokinase-Type Plasminogen Activator | 2010 |
Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor-tissue factor axis.
Topics: Animals; Colonic Neoplasms; Disease Models, Animal; Female; Humans; Male; Metabolome; Mice; Mice, Nude; Plasminogen Activator Inhibitor 1; Receptors, Aryl Hydrocarbon; Signal Transduction; Thromboplastin; Tryptophan; Venous Thromboembolism; Xenograft Model Antitumor Assays | 2019 |
Phosphatidylserine and phosphatidylethanolamine regulate the structure and function of FVIIa and its interaction with soluble tissue factor.
Topics: Fluorescence; Humans; Phosphatidylethanolamines; Phosphatidylserines; Proteolysis; Prothrombin; Structure-Activity Relationship; Thromboplastin; Tryptophan | 2021 |
Indoleamine 2,3-dioxygenase-1, a Novel Therapeutic Target for Post-Vascular Injury Thrombosis in CKD.
Topics: Animals; Aorta; Carotid Artery Injuries; Carotid Artery Thrombosis; Culture Media; Enzyme Induction; Feedback, Physiological; Female; HEK293 Cells; Humans; Indican; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Targeted Therapy; Myocytes, Smooth Muscle; Postoperative Complications; Renal Insufficiency, Chronic; Thromboplastin; Thrombosis; Tryptophan; Uremia; Vascular Surgical Procedures | 2021 |